INFINIUM
Invest Now
Start SIP in
INFINIUM
Performance
- Low
- ₹285
- High
- ₹294
- 52 Week Low
- ₹178
- 52 Week High
- ₹393
- Open Price₹294
- Previous Close₹288
- Volume2,500
Investment Returns
- Over 1 Month -3.52%
- Over 3 Month + 21.54%
- Over 6 Month -4.5%
- Over 1 Year + 26.05%
Smart Investing Starts Here Start SIP with Infinium Pharmachem for Steady Growth!
Infinium Pharmachem Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 49.1
- PEG Ratio
- -
- Market Cap Cr
- 400
- P/B Ratio
- 6.3
- Average True Range
- 11.97
- EPS
- 5.23
- Dividend Yield
- 0
- MACD Signal
- -2.55
- RSI
- 48.95
- MFI
- 33.32
Infinium Pharmachem Financials
Infinium Pharmachem Technicals
EMA & SMA
Current Price
₹287.45
-0.25
(-0.09%)

-
- Bearish Moving Average 7
-
- Bullish Moving Average 9
- 20 Day
- ₹287.88
- 50 Day
- ₹288.10
- 100 Day
- ₹283.74
- 200 Day
- ₹276.14
Resistance and Support
288.82
- R3 301.63
- R2 297.82
- R1 292.63
- S1 283.63
- S2 279.82
- S3 274.63
Infinium Pharmachem Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-05-28 | Audited Results & Others | To consider other business matters. (Revised) issue in the ratio of 1:1 of Rs. 10/-. |
2024-11-14 | Quarterly Results & Others | To consider other business matters. issue in the ratio of 1:1 of Rs. 10/-. |
2024-05-29 | Audited Results | |
2023-10-27 | Quarterly Results | |
2023-08-02 | Bonus issue |
Infinium Pharmachem F&O
About Infinium Pharmachem
- NSE Symbol
- INFINIUM
- BSE Symbol
- Managing Director
- Mr. Sanjaykumar Viththalbhai Patel
- ISIN
- INE0MRE01011
Similar Stocks to Infinium Pharmachem
Infinium Pharmachem FAQs
Infinium Pharmachem share price is ₹287 As on 19 July, 2025 | 01:06
The Market Cap of Infinium Pharmachem is ₹400 Cr As on 19 July, 2025 | 01:06
The P/E ratio of Infinium Pharmachem is 49.1 As on 19 July, 2025 | 01:06
The PB ratio of Infinium Pharmachem is 6.3 As on 19 July, 2025 | 01:06
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.